BELGRADE, Mont., July 10, 2012 /PRNewswire/ -- Bacterin International Holdings, Inc. (NYSE Amex: BONE), a leader in the development of revolutionary bone graft material and antimicrobial coatings for medical applications, announces its fourth national GPO (group purchasing organization) contract, a three-year agreement with the Premier healthcare alliance, one of the nations largest GPOs, serving over 2,600 hospitals and more than 84,000 other healthcare sites that represent over $43 billion in annual purchasing power. The agreement provides Bacterin's full biologic portfolio, including OsteoSponge®, OsteoSelect® DBM Putty, OsteoWrap®, OsteoLock®, BacFast®, hMatrix®, Sports Medicine Allografts, and traditional allografts for specially negotiated pricing to the nationwide network of hospitals and medical practices served by Premier. The group purchasing agreement became effective, after performing months of research and evaluation of the Bacterin product lines.
"We are pleased to partner with Premier, a world leader in helping deliver measurable improvements in care," said Guy Cook, Chairman and CEO of Bacterin International. "Bacterin has helped many healthcare institutions recognize cost savings on biologics by providing quality allografts with proven clinical efficacy. Receiving this award will help us reach additional hospitals and surgical centers within the Premier network of facilities and continue our commitment to reducing excessive spend while surpassing the needs of our surgeons and their patients."
About the Premier Healthcare Alliance, Malcolm Baldrige National Quality Award recipientPremier is a performance improvement alliance of more than 2,600 U.S. hospitals and 84,000-plus other healthcare sites using the power of collaboration to lead the transformation to high-quality, cost-effective care. Owned by hospitals, health systems and other providers, Premier maintains the nation's most comprehensive repository of clinical, financial and outcomes information and operates a leading healthcare purchasing network. A world leader in helping deliver measurable improvements in care, Premier has worked with the Centers for Medicare & Medicaid Services and the United Kingdom's National Health Service North West to improve hospital performance. Headquartered in Charlotte, N.C., Premier also has an office in Washington. https://premierinc.com
About BacterinBacterin International Holdings, Inc. (NYSE Amex: BONE) develops, manufactures and markets biologics products to domestic and international markets. Bacterin's proprietary methods optimize the growth factors in human allografts to create the ideal stem cell scaffold to promote bone, subchondral repair and dermal growth. These products are used in a variety of applications including enhancing fusion in spine surgery, relief of back pain, promotion of bone growth in foot and ankle surgery, promotion of cranial healing following neurosurgery and subchondral repair in knee and other joint surgeries.Bacterin's Medical Device division develops, employs, and licenses bioactive coatings for various medical device applications. Bacterin's strategic coating initiatives include antimicrobial coatings designed to inhibit biofilm formation and microbial contamination. For further information, please visit http://www.bacterin.com Important Cautions Regarding Forward-looking Statements